Synergistic antibacterial and osteogenic properties of micro-arc oxidation GO@Ag/SF composite coatings for the repair of infectious bone defects.
The GO@Ag/SF composite coating shows promise for enhancing antibacterial and osteogenic outcomes in bone defects, but human studies are needed to confirm its clinical utility.
Where it sits
this study against the rest of the cjc-1295 without dac (modified grf 1-29) corpusSummary and findings
The study evaluated a graphene oxide-supported silver nanoparticle/silk fibroin composite coating in a rat model of infectious bone defect. The coating demonstrated pH-responsive Ag+ release and enhanced antibacterial and osteogenic properties. It improved bone-implant integration and reduced inflammation in vivo.
Abstract
<h4>Background</h4>Bacterial infection and insufficient osseointegration of titanium-based implants remain major clinical challenges. Conventional drug-loaded coatings often fail to simultaneously achieve long-term antibacterial activity and the construction of an osteogenic microenvironment.<h4>Methods</h4>In this study, a graphene oxide-supported silver nanoparticle/silk fibroin (GO@Ag/SF) composite coating was developed and modified via micro-arc oxidation. By precisely controlling the GO/AgNO<sub>3</sub> volume ratio, the antibacterial and osteogenic performances of the coatings were systematically evaluated. A rat model of infectious bone defect was employed to verify the in vivo therapeutic efficacy.<h4>Results</h4>The optimized GO@Ag-2/SF coating exhibited pH-responsive sustained Ag<sup>+</sup> release, with cumulative release increasing from 0.23 μg/mL under physiological conditions to 0.69 μg/mL under acidic conditions over 672 h. Under NIR irradiation, the coating reached 59.8°C within 10 min and achieved potent antibacterial activity against <i>S. aureus</i> and <i>E. coli</i>, with inhibition rates up to 98.3 ± 1.2%. The GO@Ag-2/SF coating also promoted osteogenic differentiation by enhancing ALP activity, collagen secretion, calcium mineralization, and the expression of RUNX-2, ALP, COL-I, and OCN. In vivo, GO@Ag-2/SF reduced inflammatory infiltration and improved peri-implant bone regeneration, with increased BIC, BV/TV, and Tb.Th and reduced Tb.Sp. Moreover, pull-out testing demonstrated the highest bone-implant mechanical fixation in the GO@Ag-2/SF group, confirming enhanced functional osseointegration in the infected bone defect model.<h4>Conclusion</h4>Through the synergistic effects of its components, the GO@Ag/SF coating established a dynamic antibacterial-osteogenic balance, offering a promising strategy for the repair of infectious bone defects.
Background
Bacterial infections and poor osseointegration are significant challenges in the use of titanium-based implants. Conventional coatings often fail to provide both long-term antibacterial activity and an osteogenic environment. This study addresses these issues by developing a composite coating with potential dual benefits.
Methods
The study utilized a graphene oxide-supported silver nanoparticle/silk fibroin composite coating, modified via micro-arc oxidation. The coating's properties were evaluated in a rat model of infectious bone defect. The GO/AgNO3 volume ratio was controlled to assess antibacterial and osteogenic performance. Primary outcomes included antibacterial activity and osteogenic differentiation.
Results
The GO@Ag-2/SF coating showed pH-responsive Ag+ release, with cumulative release increasing from 0.23 μg/mL to 0.69 μg/mL over 672 hours. Under NIR irradiation, the coating reached 59.8°C within 10 minutes and demonstrated high antibacterial activity, with inhibition rates up to 98.3 ± 1.2% against S. aureus and E. coli. Osteogenic differentiation was enhanced, as indicated by increased ALP activity and collagen secretion. In vivo, the coating improved peri-implant bone regeneration and mechanical fixation.
Interpretation
The study demonstrates that the GO@Ag-2/SF coating has significant antibacterial and osteogenic properties in a rat model. While the results are promising, the clinical significance for human applications remains uncertain due to the animal model and lack of long-term data. The findings suggest potential for improved implant integration, but further research in humans is necessary.
Key findings
- Cumulative Ag+ release increased from 0.23 μg/mL to 0.69 μg/mL over 672 h.
- Inhibition rates against S. aureus and E. coli were up to 98.3 ± 1.2%.
- Coating reached 59.8°C within 10 min under NIR irradiation.
- Enhanced ALP activity, collagen secretion, and calcium mineralization observed.
- Improved BIC, BV/TV, and Tb.Th with reduced Tb.Sp in vivo.
Limitations
- rat model, no human data
- long-term durability not reported
- single-site study
- short follow-up duration